Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases

Programmed cell death protein 1 (PD-1)/PD-ligand (L)1, the immune checkpoint inhibitors have emerged as a promising strategy for the treatment of various diseases including chronic liver diseases (CLDs) such as hepatitis, liver injury and hepatocellular carcinoma (HCC). The role of PD-1/PD-L1 has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Vishakha, Khurana, Amit, Allawadhi, Prince, Banothu, Anil Kumar, Bharani, Kala Kumar, Weiskirchen, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733625/
https://www.ncbi.nlm.nih.gov/pubmed/35002724
http://dx.doi.org/10.3389/fphar.2021.790963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733625/
https://www.ncbi.nlm.nih.gov/pubmed/35002724
http://dx.doi.org/10.3389/fphar.2021.790963

Ejemplares similares